ArticleFrontiers in oncology2022

Treatment Response, Survival Benefit and Safety Profile of PD-1 Inhibitor Plus Apatinib Versus Apatinib Monotherapy in Advanced Colorectal Cancer Patients.

Dengdeng Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.